|
Video: What is a Stock Split?
|
|
PLx Pharma is a commercial-stage drug delivery platform technology company focused on improving how and where active pharmaceutical ingredients are absorbed in the gastrointestinal tract via its clinically-validated and patent-protected PLxGuard technology. Co. has two Food and Drug Administration approved products, VAZALORE® 81 mg and VAZALORE® 325 mg, which are liquid-filled aspirin capsules for over-the-counter distribution. The complex inside the capsule allows for targeted release of aspirin, limiting its direct contact with the stomach lining. VAZALORE delivers absorption for pain relief plus the lifesaving benefits of aspirin. According to our PLXP split history records, PLXP has had 1 split. | |
|
PLXP (PLXP) has 1 split in our PLXP split history database. The split for PLXP took place on April 20, 2017. This was a 1 for 8 reverse split, meaning for each 8 shares of PLXP owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 125 share position following the split.
When a company such as PLXP conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.
Looking at the PLXP split history from start to finish, an original position size of 1000 shares would have turned into 125 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into PLXP shares, starting with a $10,000 purchase of PLXP, presented on a split-history-adjusted basis factoring in the complete PLXP split history.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
03/31/2014 |
|
End date: |
04/13/2023 |
|
Start price/share: |
$80.64 |
|
End price/share: |
$0.04 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-99.95% |
|
Average Annual Total Return: |
-56.44% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$5.46 |
|
Years: |
9.04 |
|
|
|
Date |
Ratio |
04/20/2017 | 1 for 8 |
|
|